Professor Jemima Mellerio

Sub-specialties: Adult Dermatology, Paediatric Dermatology, Sun Damage, Skin Cancer, Dermatology, Mole Checks, Moles, Acne, Eczema, Birthmarks, Epidermolysis Bullosa, Pigmentation Disorders, Ichthyosis, Keratoderma.

Overview

02036532007

Overview

Prof Mellerio treats a range of dermatology issues including skin problems, birthmarks and hair disorders, as well treating sun damage and skin cancers. Additionally, she is an international expert in the diagnosis and treatment of genetic skin diseases including ichthyosis, epidermolysis bullosa, ectodermal dysplasia and other related disorders.

About Professor Jemima Mellerio

Professor Jemima Mellerio is an experienced consultant in all areas of general adult and paediatric dermatology and is the Chief of Dermatology at St John’s Institute of Dermatology and Guy’s and St Thomas’ NHS Foundation Trust.

She is on the Executive Committees of the Royal Society of Medicine Section of Dermatology, the British Society of Paediatric Dermatology and the International Society of Pediatric Dermatology. She is also a Fellow of the Royal College of Physicians and a member of the British Association of Dermatologists.

Prof Mellerio lectures both nationally and internationally in her speciality and has over 150 peer-reviewed publications as well as authored many chapters in prominent textbooks of dermatology. Research interests include epidermolysis bullosa and other genodermatoeses, as well as other aspects of general adult and paediatric dermatology.

Professor Jemima Mellerio gained a first class BSc in Physiology at the London Hospital Medical College and undertook her specialist dermatology training at St John’s Institute of Dermatology and King’s College Hospital, joining the Specialist Register for Dermatology in 2002.

In 2003, she was the dermatologist for the Paediatric EB Service at Great Ormond Street Hospital for Children NHS Foundation Trust for 14 years. At St John’s Institute of Dermatology, she has been the Chief of Dermatology from 2018 to date.

After completing her MD thesis in Genotype-Phenotype Correlation in EB Professor Mellerio has continued to work on gene discovery for novel forms of EB and promotes holistic multidisciplinary care for paediatric and adult skin disorders, rare disease clinical trials, teaching and training.

Areas of Expertise

Prof Jemima Mellerio performs a range of treatments including:

General dermatology
Pa ediatric dermatology
Mole checks

Some of the conditions she commonly treats are:

Skin cancer
Moles
Eczema
Acne
Birthmarks
Epidermolysis bullosa
Pigmentary disorders
Ichthyosis
Keratoderma

Additional Information

Qualifications

BSc Physiology 1988
MB BS (London) 1991
MRCP (UK) 1994
MD 2000
FRCP (UK) 2007

Awards

Chief of Dermatology, St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital September 2018 to date
Lead, Adult Epidermolysis Bullosa Service, Guy’s and St Thomas’ Hospital 2003 to date
Lead, Paediatric and Genetic Dermatology, Guy’s and St Thomas’ Hospital 2006-2018
President, Dermatology Section, Royal Society of Medicine 2018-2019
Co-chair European Reference Network-Skin Epidermolysis Bullosa Group 2016-2020
Member Executive committee British Society of Paediatric Dermatology 2014 to date

Memberships

British Association of Dermatologists
British Society for Paediatric Dermatology
British Society for Investigative Dermatology
European Society for Pediatric Dermatology
European Association of Dermatovenereology
International Society for Pediatric Dermatology
European Dermatology Forum
European Society for Dermatological Research
Royal Society of Medicine, Section of Dermatology

Research Highlights

Prof Jemima Mellerio has authored over 150 peer-reviewed publications including:

Key Publications

Epidermolysis bullosa. Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, Magin TM, Marinkovich MP, Marshall JF, McGrath JA, Mellerio JE, Polson R, Heagerty AH. Nat Rev Dis Primers. 2020; 6: 78.
Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility. Has C, Bauer JW, Bodemer C, Bolling M, Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich P, Martinez AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K, Uitto J, Woodley DT, Zambruno G, Mellerio JE. Br J Dermatol. 2020; 183: 614-27. https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.18921
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa – best clinical practice guidelines. Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, Goldberg D, Halmos GB, Harries M, Jonkman MF, Lucky A, Martinez AE, Maubec E, Morris S, Murrell DF, Palisson F, Pillay EI, Robson A, Salas-Alanis JC, McGrath JA. Br J Dermatol 2016; 174: 56-67.
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.14104
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Prmanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA. J Am Acad Dermatol. 2020; 83: 447-54.
https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933130-5

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.